(Q54360356)

English

The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

Nicolai Burzlaff

object named as

Nicolai Burzlaff

4

0 references

Kai-Uwe Eckardt

7

object named as

Kai-Uwe Eckardt

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

author name string

Zhendi Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

Gunnar Schley

2

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

Gazi Türkoglu

3

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

Kerstin U Amann

5

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

Carsten Willam

6

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

Wanja M Bernhardt

8

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

language of work or name

0 references

publication date

8 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

27

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

3

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

929-936

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

The RIFLE criteria and mortality in acute kidney injury: A systematic review

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

HIF activation protects from acute kidney injury

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

A conserved family of prolyl-4-hydroxylases that modify HIF

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Hypoxia-inducible factors and the response to hypoxic stress

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Purification and characterization of hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

In vivo functions of the prolyl-4-hydroxylase domain oxygen sensors: direct route to the treatment of anaemia and the protection of ischaemic tissues

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Protective effect of erythropoietin on renal ischemia and reperfusion injury

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Application of a proteolysis/mass spectrometry method for investigating the effects of inhibitors on hydroxylase structure.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

HIF-2alpha regulates murine hematopoietic development in an erythropoietin-dependent manner

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

New agents that stimulate erythropoiesis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Recent advances in erythropoietic agents in renal anemia

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Hypoxia and the HIF system in kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Erythropoietin protects against ischaemic acute renal injury

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Human, rat, and mouse kidney cells express functional erythropoietin receptors

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Identification of the renal erythropoietin-producing cells using transgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR379

21 January 2018

Identifiers

10.1093/NDT/GFR379

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21742784

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54360356&oldid=1743746294"